[
  {
    "ts": null,
    "headline": "Applied Materials Earnings, Inflation Data: Still to Come This Week",
    "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
    "url": "https://finnhub.io/api/news?id=bff6be15e4da5bf84580943e4c5315a089a4801eefaad3cb5bcce4df1cc8199f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770918024,
      "headline": "Applied Materials Earnings, Inflation Data: Still to Come This Week",
      "id": 139066871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
      "url": "https://finnhub.io/api/news?id=bff6be15e4da5bf84580943e4c5315a089a4801eefaad3cb5bcce4df1cc8199f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Stock to Avoid or Bad News Buy?",
    "summary": "Moderna stock was a highflier in early pandemic days as sales of its coronavirus vaccine soared.",
    "url": "https://finnhub.io/api/news?id=b85b7b7bb6b1385e86234e34d0f910b82a375f3052f9e80d8d93c5283ccb69c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770913800,
      "headline": "Moderna: Stock to Avoid or Bad News Buy?",
      "id": 139066734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock was a highflier in early pandemic days as sales of its coronavirus vaccine soared.",
      "url": "https://finnhub.io/api/news?id=b85b7b7bb6b1385e86234e34d0f910b82a375f3052f9e80d8d93c5283ccb69c6"
    }
  },
  {
    "ts": null,
    "headline": "Prasad overruled FDA scientists on Moderna application, STAT says",
    "summary": "Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, overruled the agency’s reviewers in refusing to accept Moderna’s (MRNA) application for a new influenza vaccine, Lizzy Lawrence of STAT reports, citing three officials familiar with the matter. A team of career scientists was ready to review Moderna’s application, sources told the website. Shares of Moderna are down 10% to $37.93 in morning trading.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powe",
    "url": "https://finnhub.io/api/news?id=54670a6c1d861b9a3ff39fc3555e0ffc1916c2d774987d455a9653a39c5b9d41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770911160,
      "headline": "Prasad overruled FDA scientists on Moderna application, STAT says",
      "id": 139061211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, overruled the agency’s reviewers in refusing to accept Moderna’s (MRNA) application for a new influenza vaccine, Lizzy Lawrence of STAT reports, citing three officials familiar with the matter. A team of career scientists was ready to review Moderna’s application, sources told the website. Shares of Moderna are down 10% to $37.93 in morning trading.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powe",
      "url": "https://finnhub.io/api/news?id=54670a6c1d861b9a3ff39fc3555e0ffc1916c2d774987d455a9653a39c5b9d41"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Rivian stock surges on earnings beat, Pinterest plunges, Crocs soars",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=d4dd48ca25b2187354f7dcfc6346422918399bff26bd103e193016e0ea443d7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770901879,
      "headline": "Earnings live: Rivian stock surges on earnings beat, Pinterest plunges, Crocs soars",
      "id": 139074769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=d4dd48ca25b2187354f7dcfc6346422918399bff26bd103e193016e0ea443d7d"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=8e84526abcc25859cd293d5b80689e33bfcf1cbb07ef9543d0b064954b796ede",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770901879,
      "headline": "Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges",
      "id": 139055907,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=8e84526abcc25859cd293d5b80689e33bfcf1cbb07ef9543d0b064954b796ede"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader",
    "summary": "Moderna Inc (NASDAQ:MRNA) has delivered a 37% gain year-to-date, dramatically outpacing the biotech sector’s 0.4% YTD return. In fact, Moderna has the 12th-best gains in the entire S&P 500 so far in 2026! The rally reflects strategic wins and pipeline progress, though recent regulatory turbulence has tested investor conviction. Let’s dive into why Moderna is ... Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader",
    "url": "https://finnhub.io/api/news?id=7ae9860694ba1ec9557bf3a768db7cffbfc8d983c31ef61ce46a61bfd72f0fa2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770899225,
      "headline": "Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader",
      "id": 139056447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Inc (NASDAQ:MRNA) has delivered a 37% gain year-to-date, dramatically outpacing the biotech sector’s 0.4% YTD return. In fact, Moderna has the 12th-best gains in the entire S&P 500 so far in 2026! The rally reflects strategic wins and pipeline progress, though recent regulatory turbulence has tested investor conviction. Let’s dive into why Moderna is ... Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader",
      "url": "https://finnhub.io/api/news?id=7ae9860694ba1ec9557bf3a768db7cffbfc8d983c31ef61ce46a61bfd72f0fa2"
    }
  },
  {
    "ts": null,
    "headline": "Company News for Feb 12, 2026",
    "summary": "Companies In The Article Are:MRNA, THC, SHOP,TMUS",
    "url": "https://finnhub.io/api/news?id=031ab0b2ee450732a593f94200796130e51a85d401bddc53f815e320afb30bff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770896400,
      "headline": "Company News for Feb 12, 2026",
      "id": 139056103,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Companies In The Article Are:MRNA, THC, SHOP,TMUS",
      "url": "https://finnhub.io/api/news?id=031ab0b2ee450732a593f94200796130e51a85d401bddc53f815e320afb30bff"
    }
  },
  {
    "ts": null,
    "headline": "CPI Data, Coinbase Earnings, Home Sales: Still to Come This Week",
    "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
    "url": "https://finnhub.io/api/news?id=5603b6bda35ce161ada0b39ba90daac6b560bdd54c7c3905463fcaad5edc706a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770883770,
      "headline": "CPI Data, Coinbase Earnings, Home Sales: Still to Come This Week",
      "id": 139053915,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
      "url": "https://finnhub.io/api/news?id=5603b6bda35ce161ada0b39ba90daac6b560bdd54c7c3905463fcaad5edc706a"
    }
  },
  {
    "ts": null,
    "headline": "AI Agents and the Jobs Report Jitter: A Wall Street Balancing Act",
    "summary": "Wall Street paused its recent rally as a robust January jobs report cooled expectations for a swift Federal Reserve pivot, while the burgeoning \"AI agent\" narrative sent shockwaves through the software sector, creating a stark divide between winners and losers.",
    "url": "https://finnhub.io/api/news?id=b055d53cdfc004c1e43e0b5669dfdd1ce1ae35f7a471724f50a595ca94449076",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770882635,
      "headline": "AI Agents and the Jobs Report Jitter: A Wall Street Balancing Act",
      "id": 139053786,
      "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_4_df6d61be87.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Wall Street paused its recent rally as a robust January jobs report cooled expectations for a swift Federal Reserve pivot, while the burgeoning \"AI agent\" narrative sent shockwaves through the software sector, creating a stark divide between winners and losers.",
      "url": "https://finnhub.io/api/news?id=b055d53cdfc004c1e43e0b5669dfdd1ce1ae35f7a471724f50a595ca94449076"
    }
  },
  {
    "ts": null,
    "headline": "What To Expect From Moderna’s (MRNA) Q4 Earnings",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before market hours. Here’s what to look for.",
    "url": "https://finnhub.io/api/news?id=e7a4f2d2cd8d1a0f8122397498da8a58a2fc7e6cc834cdb14729c83ec572808a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770865297,
      "headline": "What To Expect From Moderna’s (MRNA) Q4 Earnings",
      "id": 139052342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before market hours. Here’s what to look for.",
      "url": "https://finnhub.io/api/news?id=e7a4f2d2cd8d1a0f8122397498da8a58a2fc7e6cc834cdb14729c83ec572808a"
    }
  },
  {
    "ts": null,
    "headline": "Why the FDA Blocked Moderna’s New Flu Shot",
    "summary": "The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.",
    "url": "https://finnhub.io/api/news?id=f2f496e28b99d3febf88be449a6e1b01124e53a1fd57e4d030753169e98fa180",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770861600,
      "headline": "Why the FDA Blocked Moderna’s New Flu Shot",
      "id": 139052343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.",
      "url": "https://finnhub.io/api/news?id=f2f496e28b99d3febf88be449a6e1b01124e53a1fd57e4d030753169e98fa180"
    }
  }
]